May 13, 2020 / 07:40PM GMT
Lut Ming Cheng - BofA Merrill Lynch, Research Division - Associate
Good afternoon. It's my pleasure this afternoon to introduce you the company, Alector.
Presenting for Alector company is Shehnaaz Suliman, who is the President and Chief Operating Officer. I'm Brian Cheng, the associate on Tazeen's midcap biotech team at Bank of America.
Shehnaaz, I believe that you have uploaded a deck here, and I will let you take it from here.
Shehnaaz Suliman - Alector, Inc. - President & COO
Thank you, Brian. Good afternoon, everyone, and it's a great pleasure to be here today to provide an update on Alector.
My name is Shehnaaz Suliman, and I'm the President and COO. I joined the Alector team in December because, along with everyone here, we share a strong belief that our work is scientifically and clinically meaningful and has the potential to be transformational for millions of patients living with dementia. As a physician, drug developer and dealmaker in the industry for over 20 years and having run global clinical trials in Alzheimer's
Alector Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers